These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 396401

  • 1. [Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)].
    Ueda Y, Tojo S, Hatano M, Furukawa T, Yoshinaga K, Kinoshita Y, Takeuchi J, Kato E, Ohno J, Kobayashi K, Abe H, Omae S.
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1171-83. PubMed ID: 396401
    [No Abstract] [Full Text] [Related]

  • 2. [The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Tesutani T, Yamamoto M, Fujimoto Y, Okubo A, Oka G.
    Nihon Jinzo Gakkai Shi; 1979 Feb; 21(2):135-55. PubMed ID: 381736
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.
    Ishikawa H, Honjo A, Hayashi M, Hamaguchi T, Morita T, Shindo T, Tetsutani T, Yamamoto T, Okubo H, Oka G.
    Arzneimittelforschung; 1982 Feb; 32(3):301-9. PubMed ID: 7200790
    [No Abstract] [Full Text] [Related]

  • 4. [Dipyridamole therapy in the nephrotic syndrome (author's transl)].
    Tojo S, Narita M, Suzuki H, Sano M, Koyama A, Tsuchiya T, Yamamoto S, Tsuchida H, Shishido H, Watanabe K.
    Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):255-66. PubMed ID: 671851
    [No Abstract] [Full Text] [Related]

  • 5. Dipyridamole therapy in the nephrotic syndrome.
    Tojo S, Narita M, Koyama A, Sano M, Suzuki H, Tsuchiya T, Tsuchida H, Yamamoto S, Shishido H.
    Contrib Nephrol; 1978 Mar; 9():111-27. PubMed ID: 352614
    [Abstract] [Full Text] [Related]

  • 6. Effect of dipyridamole on proteinuria of nephrotic syndrome.
    Okada S, Kurata N, Ota Z, Ofuji T.
    Lancet; 1981 Mar 28; 1(8222):719-20. PubMed ID: 6110931
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J, Wouda AA, Kallenberg CG, Wesseling H.
    Vasa Suppl; 1987 Mar 28; 18():71-5. PubMed ID: 3299819
    [No Abstract] [Full Text] [Related]

  • 8. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
    Statham B, Finlay AY, Marks R.
    Acta Derm Venereol; 1981 Mar 28; 61(3):270-1. PubMed ID: 6167117
    [Abstract] [Full Text] [Related]

  • 9. [Dipyridamole and warfarin in patients with artificial heart valve prosthesis: double-blind tests].
    Ciavarella N, Antoncecchi S, D'Elia N.
    Cardiologia; 1985 Apr 28; 30(4):301-7. PubMed ID: 3914360
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of claudication with dipyridamole and aspirin.
    Libretti A, Catalano M.
    Int J Clin Pharmacol Res; 1986 Apr 28; 6(1):59-60. PubMed ID: 3514494
    [Abstract] [Full Text] [Related]

  • 11. Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis.
    Can Med Assoc J; 1976 Dec 18; 115(12):1209-10. PubMed ID: 793706
    [Abstract] [Full Text] [Related]

  • 12. [Alteration of selectivity in proteinuria through relapse of steroid sensitive nephrosis in childhood (author's transl)].
    Rossipal E.
    Padiatr Padol; 1971 Dec 18; 6(4):365-70. PubMed ID: 5164152
    [No Abstract] [Full Text] [Related]

  • 13. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. I. General protocol. From the DAMAD Study Group (author's transl)].
    Diabete Metab; 1982 Jun 18; 8(2):91-6. PubMed ID: 7049782
    [Abstract] [Full Text] [Related]

  • 14. [Cell-mediated immunity and effects of cyclophosphamide on primary nephrotic syndrome (author's transl)].
    Okura T, Matsuo S, Kumon S, Hibi I, Tamaki S, Watanabe Y, Kinoshita Y.
    Nihon Jinzo Gakkai Shi; 1981 Nov 18; 23(11):1395-403. PubMed ID: 7334719
    [No Abstract] [Full Text] [Related]

  • 15. Selectivity of proteinuria in nephrotic syndrome.
    Tay CH, Chen TM, Wee R.
    Singapore Med J; 1971 Aug 18; 12(4):233-6. PubMed ID: 5002036
    [No Abstract] [Full Text] [Related]

  • 16. Dipyridamole - is it a bronchodilator?
    Ruffin RE, Newhouse MT.
    Eur J Respir Dis; 1981 Aug 18; 62(2):123-6. PubMed ID: 7016567
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of steroid-enhanced proteinuria in nephrotic patients.
    Kumagai H, Hishida A, Nagase M, Honda N.
    Nihon Jinzo Gakkai Shi; 1987 Mar 18; 29(3):277-81. PubMed ID: 3613255
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of corticosteroid and indomethacin treatment on proteinuria].
    Michielsen P, Lambert PP.
    Bull Mem Soc Med Hop Paris; 1967 Feb 10; 118(3):217-32. PubMed ID: 6058837
    [No Abstract] [Full Text] [Related]

  • 19. Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
    Hopper AH, Tindall H, Davies JA.
    Nephrol Dial Transplant; 1989 Feb 10; 4(2):140-3. PubMed ID: 2496357
    [Abstract] [Full Text] [Related]

  • 20. Effects of the antiplatelet agents, dipyridamole and dilazep dihydrochloride, on in vivo platelet function and proteinuria.
    Inage H, Koyama A, Narita M, Tojo S.
    Nihon Jinzo Gakkai Shi; 1985 Sep 10; 27(9):1261-70. PubMed ID: 4087547
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.